What's new

Orphan designation: Felzartamab Treatment of in solid organ transplantation, 13/12/2024 Positive

Orphan designation: Felzartamab Treatment of in solid organ transplantation, 13/12/2024 Positive

Apr 4, 2025 - 11:33
 0
Orphan designation: Felzartamab Treatment of in solid organ transplantation, 13/12/2024 Positive
Orphan designation: Felzartamab Treatment of in solid organ transplantation, 13/12/2024 Positive
Read More

Tags:

Previous Article

Orphan designation: Autologous T lymphocyte-enriched population of cells transdu...

Next Article

Orphan designation: deucrictibant monohydrate Treatment of bradykinin-mediated a...

Related Posts

Herbal medicinal product: Tribuli terrestris herbaArray, D: Draft under discussion

Herbal medicinal product: Tribuli terrestris herbaArray...

Feb 25, 2025  0

Combination of cystic fibrosis medicines to treat patients with rare mutations

Combination of cystic fibrosis medicines to treat patie...

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Hexacima, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed), Date of authorisation: 17/04/2013, Date of refusal: 22/02/2013, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0